Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMS

Summary

Prospective, single center, open label, phase I/IIa escalating dose study. To evaluate the safety and efficacy of escalating doses of SCM-010 in subjects with SPMS.

Timeline

Start

2024-02-01

Primary completion

2025-02-01

Completion

2025-02-01

Outcome

Outcome not reported

Stopped (Business): “Due to sponsor decision”

Drugs

Indications